News

NHS England commissions first new TB drugs in 50 years


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

NHS England commissions first new TB drugs in 50 years

Date: 26/08/2015

NHS England has published a new Clinical Commissioning Policy making Janssen’s Sirturo and Otsuka’s Deltyba routinely available on the National Health Service for the treatment of pulmonary multi-drug resistant tuberculosis, offering patients easier access to the first novel therapies in nearly 50 years.

 

According to the policy, doctors can now prescribe Sirturo (bedaquiline) and Deltyba (delamanid) more easily as part of appropriate combination therapies for adult patients, when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

For more click here

Source: PharmaTimes

© Catalyst Innovation Portal 2019